May 7, 2021

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge

2021_05_H_PR_Waiver of Intellectual Property Rights for COVID-19 Vaccines – EuropaBio’s Position
November 25, 2020

An EU IP Action Plan for strong industrial ecosystems

An EU IP Action Plan for strong industrial ecosystems
Become a member